• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Happiness Development Group Limited

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HAPP alert in real time by email

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 2024

     

    PARANOVUS ENTERTAINMENT TECHNOLOGY LIMITED

    (Exact name of registrant as specified in its charter)

     

    No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City

    Fujian Province, People’s Republic of China

    +86-0599-782-8808

    (Address of Principal Executive Office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒    Form 40-F ☐

     

     

     

     

     

     

    Explanatory Note

     

    Paranovus Entertainment Technology Limited (the “Company”) is furnishing this Form 6-K to provide its financial results for the six months ended September 30, 2023.

     

    The Company hereby furnishes the following documents as exhibits to this report: “Unaudited Condensed Consolidated Financial Statements for the Six Months Ended September 30, 2023 and 2022” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

     

    Exhibits

     

    Exhibit No.   Description
    99.1   Unaudited Condensed Consolidated Financial Statements for the Six Months Ended September 30, 2023 and 2022
    99.2   Management’s Discussion and Analysis of Financial Condition and Results of Operations
    101.INS   Inline XBRL Instance Document.
    101.SCH   Inline XBRL Taxonomy Extension Schema Document.
    101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
    101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
    101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
    101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
    104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

     

    1

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Paranovus Entertainment Technology Limited
         
    Date: January 12, 2024 By: /s/ Xuezhu Wang
      Name:   Xuezhu Wang
      Title: Chief Executive Officer

     

     

    2

     

     

    Get the next $HAPP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HAPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HAPP
    SEC Filings

    View All

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/23/24 4:15:34 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 5:25:25 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Happiness Development Group Limited Announces Name Change to Paranovus Entertainment Technology Ltd.

    NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p

    3/13/23 9:10:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2

    10/27/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Announces 1 for 20 Reverse Share Split

    NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o

    10/10/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Financials

    Live finance-specific insights

    View All

    Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

    NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service

    1/6/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Acquires Majority Ownership in Fujian Shennong

    NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a

    10/25/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

    NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo

    1/22/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:48:39 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:52:26 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care